BackPrecision Peptide Company Overview
Precision Peptide Company Inc

Precision Peptide Company P/E Ratio

Precision Peptide Company (BPC.CN) has a P/E ratio of -1.67, below the sector sector average of 22.75.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

-1.67

P/E Ratio

-1.67

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Precision Peptide Company (BPC.CN) FAQ

The latest P/E ratio for BPC.CN is -1.67. That is below the sector sector average of 22.75. Investors often review this figure alongside Precision Peptide Company's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, BPC.CN currently prints -1.67 for P/E ratio, while the sector average sits near 22.75. That is roughly 107.3% below the sector mean. Large gaps often invite a closer look at Precision Peptide Company's growth, margins, and balance sheet.

A P/E ratio of -1.67 for Precision Peptide Company is not 'good' or 'bad' on its own. Compare it with the peer average (22.75) and with BPC.CN's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting BPC.CN's P/E ratio (-1.67), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers